162 related articles for article (PubMed ID: 33006395)
21. Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).
Weller D; Menon U; Zalounina Falborg A; Jensen H; Barisic A; Knudsen AK; Bergin RJ; Brewster DH; Cairnduff V; Gavin AT; Grunfeld E; Harland E; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Harrison S; Reguilon I; ; Vedsted P
BMJ Open; 2018 Nov; 8(11):e023870. PubMed ID: 30482749
[TBL] [Abstract][Full Text] [Related]
22. International differences in lung cancer survival by sex, histological type and stage at diagnosis: an ICBP SURVMARK-2 Study.
Araghi M; Fidler-Benaoudia M; Arnold M; Rutherford M; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Gavin A; Kozie S; Little A; Møller B; St Jacques N; Tervonen H; Walsh P; Woods R; O'Connell DL; Baldwin D; Elwood M; Siesling S; Bray F; Soerjomataram I; ; ; ; ;
Thorax; 2022 Apr; 77(4):378-390. PubMed ID: 34282033
[TBL] [Abstract][Full Text] [Related]
23. International trends in oesophageal cancer survival by histological subtype between 1995 and 2014.
Morgan E; Soerjomataram I; Gavin AT; Rutherford MJ; Gatenby P; Bardot A; Ferlay J; Bucher O; De P; Engholm G; Jackson C; Kozie S; Little A; Møller B; Shack L; Tervonen H; Thursfield V; Vernon S; Walsh PM; Woods RR; Finley C; Merrett N; O'Connell DL; Reynolds JV; Bray F; Arnold M
Gut; 2021 Feb; 70(2):234-242. PubMed ID: 32554620
[TBL] [Abstract][Full Text] [Related]
24. The International Cancer Benchmarking Partnership: an international collaboration to inform cancer policy in Australia, Canada, Denmark, Norway, Sweden and the United Kingdom.
Butler J; Foot C; Bomb M; Hiom S; Coleman M; Bryant H; Vedsted P; Hanson J; Richards M;
Health Policy; 2013 Sep; 112(1-2):148-55. PubMed ID: 23693117
[TBL] [Abstract][Full Text] [Related]
25. Shifting incidence and survival of epithelial ovarian cancer (1995-2014): A SurvMark-2 study.
Cabasag CJ; Arnold M; Rutherford M; Ferlay J; Bardot A; Morgan E; Butler J; O'Connell DL; Nelson G; Høgdall C; Schnack T; Gavin A; Elwood M; Hanna L; Gourley C; De P; Saint-Jacques N; Mørch LS; Woods RR; Altman AD; Sykes P; Cohen PA; McNally O; Møller B; Walsh P; Morrison DS; Bray F; Soerjomataram I
Int J Cancer; 2023 May; 152(9):1763-1777. PubMed ID: 36533660
[TBL] [Abstract][Full Text] [Related]
26. An investigation of routes to cancer diagnosis in 10 international jurisdictions, as part of the International Cancer Benchmarking Partnership: survey development and implementation.
Weller D; Vedsted P; Anandan C; Zalounina A; Fourkala EO; Desai R; Liston W; Jensen H; Barisic A; Gavin A; Grunfeld E; Lambe M; Law RJ; Malmberg M; Neal RD; Kalsi J; Turner D; White V; Bomb M; Menon U;
BMJ Open; 2016 Jul; 6(7):e009641. PubMed ID: 27456325
[TBL] [Abstract][Full Text] [Related]
27. An international comparison study of stage of colorectal cancer at diagnosis: how does New Zealand compare?
Samson P; O'Grady G; Keating J
N Z Med J; 2009 May; 122(1294):74-83. PubMed ID: 19465950
[TBL] [Abstract][Full Text] [Related]
28. Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Johnson SA; Swann R; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; May L; McClure CA; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJS; Thomson CS; Wang H; Woods RR; You H; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):338-351. PubMed ID: 38423048
[TBL] [Abstract][Full Text] [Related]
29. Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
McPhail S; Barclay ME; Swann R; Johnson SA; Alvi R; Barisic A; Bucher O; Creighton N; Denny CA; Dewar RA; Donnelly DW; Dowden JJ; Downie L; Finn N; Gavin AT; Habbous S; Huws DW; Kumar SE; May L; McClure CA; Morrison DS; Møller B; Musto G; Nilssen Y; Saint-Jacques N; Sarker S; Shack L; Tian X; Thomas RJ; Wang H; Woods RR; You H; Zhang B; Lyratzopoulos G;
Lancet Oncol; 2024 Mar; 25(3):352-365. PubMed ID: 38423049
[TBL] [Abstract][Full Text] [Related]
30. The survival gap between young and older patients after surgical resection for colorectal cancer remains largely based on early mortality: A EURECCA comparison of four European countries.
Bahadoer RR; Bastiaannet E; Peeters KCMJ; van Eycken E; Verbeeck J; Guren MG; Kørner H; Martling A; Johansson R; van de Velde CJH; Dekker JWT
J Geriatr Oncol; 2022 Jul; 13(6):803-812. PubMed ID: 35527207
[TBL] [Abstract][Full Text] [Related]
31. Population-based cancer staging for oesophageal, gastric, and pancreatic cancer 2012-2014: International Cancer Benchmarking Partnership SurvMark-2.
Cabasag CJ; Arnold M; Piñeros M; Morgan E; Brierley J; Hofferkamp J; Kehoe S; Butler J; Bucher O; Bray F; Soerjomataram I; Parkin DM
Int J Cancer; 2021 Sep; 149(6):1239-1246. PubMed ID: 33990959
[TBL] [Abstract][Full Text] [Related]
32. Cancer survival in Africa, central and south America, and Asia (SURVCAN-3): a population-based benchmarking study in 32 countries.
Soerjomataram I; Cabasag C; Bardot A; Fidler-Benaoudia MM; Miranda-Filho A; Ferlay J; Parkin DM; Ranganathan R; Piñeros M; Znaor A; Mery L; Joko-Fru YW; Dikshit R; Sankaranarayanan R; Swaminathan R; Bray F;
Lancet Oncol; 2023 Jan; 24(1):22-32. PubMed ID: 36603919
[TBL] [Abstract][Full Text] [Related]
33. Conditional survival of cancer patients: an Australian perspective.
Yu XQ; Baade PD; O'Connell DL
BMC Cancer; 2012 Oct; 12():460. PubMed ID: 23043308
[TBL] [Abstract][Full Text] [Related]
34. Poor staging and treatment are likely to be behind low bowel cancer survival in UK.
Kmietowicz Z
BMJ; 2013 Apr; 346():f2485. PubMed ID: 23596232
[No Abstract] [Full Text] [Related]
35. Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival?
Forbes LJ; Simon AE; Warburton F; Boniface D; Brain KE; Dessaix A; Donnelly C; Haynes K; Hvidberg L; Lagerlund M; Lockwood G; Tishelman C; Vedsted P; Vigmostad MN; Ramirez AJ; Wardle J;
Br J Cancer; 2013 Feb; 108(2):292-300. PubMed ID: 23370208
[TBL] [Abstract][Full Text] [Related]
36. Time intervals and routes to diagnosis for lung cancer in 10 jurisdictions: cross-sectional study findings from the International Cancer Benchmarking Partnership (ICBP).
Menon U; Vedsted P; Zalounina Falborg A; Jensen H; Harrison S; Reguilon I; Barisic A; Bergin RJ; Brewster DH; Butler J; Brustugun OT; Bucher O; Cairnduff V; Gavin A; Grunfeld E; Harland E; Kalsi J; Knudsen AK; Lambe M; Law RJ; Lin Y; Malmberg M; Turner D; Neal RD; White V; Weller D
BMJ Open; 2019 Nov; 9(11):e025895. PubMed ID: 31776134
[TBL] [Abstract][Full Text] [Related]
37. Colorectal cancer survival in the Nordic countries and the United Kingdom: excess mortality risk analysis of 5 year relative period survival in the period 1999 to 2000.
Engholm G; Kejs AM; Brewster DH; Gaard M; Holmberg L; Hartley R; Iddenden R; Møller H; Sankila R; Thomson CS; Storm HH
Int J Cancer; 2007 Sep; 121(5):1115-22. PubMed ID: 17455250
[TBL] [Abstract][Full Text] [Related]
38. Colon cancer in Luxembourg: a national population-based data report, 1988-1998.
Scheiden R; Pescatore P; Wagener Y; Kieffer N; Capesius C
BMC Cancer; 2005 May; 5():52. PubMed ID: 15913456
[TBL] [Abstract][Full Text] [Related]
39. Trends in net survival from colon cancer in six European Latin countries: results from the SUDCAN population-based study.
Faivre J; Bossard N; Jooste V;
Eur J Cancer Prev; 2017 Jan; 26 Trends in cancer net survival in six European Latin Countries: the SUDCAN study():S40-S47. PubMed ID: 28005604
[TBL] [Abstract][Full Text] [Related]
40. Trends in the overall survival of cancer patients diagnosed 1964-2003 in the Nordic countries followed up to the end of 2006: the importance of case-mix.
Storm HH; Kejs AM; Engholm G; Tryggvadóttir L; Klint A; Bray F; Hakulinen T
Acta Oncol; 2010 Jun; 49(5):713-24. PubMed ID: 20491527
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
